{'fraction_non_alphanumeric': 0.05902480752780154, 'fraction_numerical': 0.04961505560307956, 'mean_word_length': 4.391705069124424, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effect of T6 Treatment on Low-Cycle Fatigue Properties of Al-6Zn-2.5Mg-2Cu-0.1Zr-0.1Sc Alloy

The low-cycle fatigue behaviors of as-extruded and T6 treated Al-6Zn-2.5Mg-2Cu-0.1Zr-0.1Sc alloys at room temperature have been investigated under those total-strain amplitudes ranged from 0.3% to 1.0%, and the influence of T6 treatment on the low-cycle fatigue properties of Al-6Zn-2.5Mg-2Cu-0.1Zr-0.1Sc alloy was clarified. The experimental results show that during fatigue deformation, the significant cyclic strain hardening and stable cyclic stress response can be noted for both as-extruded and T6 treated Al-6Zn-2.5Mg-2Cu-0.1Zr-0.1Sc alloys. The fatigue life of as-extruded Al-6Zn-2.5Mg-2Cu-0.1Zr-0.1Sc alloy at all strain amplitudes is longer than that of the alloy subjected to T6 aging treatment. The relationship between both elastic and plastic strain amplitudes with reversals to failure shows a monotonic linear behavior, and can be described by the Basquin and Coffin-Manson equations, respectively. The T6 treatment can significantly increase the cyclic strain hardening exponent and cyclic strength coefficient of extruded Al-6Zn-2.5Mg-2Cu-0.1Zr-0.1Sc alloy.